Bone marrow transplantation from unrelated donors for genetic diseases following conditioning with Busulphan and Cyclophosphamide
Vellodi, A.; Jurges, E.; el-Tumi, M.; Abdul-Ahad, A.; Hobbs, J.R.
Bone Marrow Transplantation 7(Suppl 2): 70
1991
ISSN/ISBN: 0268-3369 PMID: 1878726 Document Number: 368344
Document emailed within 1 workday
Related Documents
Russell, S.; Vowels, M. 1992: Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia Transplantation Proceedings 24(1): 183Angelucci, E.; Polchi, P.; Lucarelli, G.; Galimberti, M.; Baronciani, D.; Giardini, C.; Durazzi, S.M.; Moretti, L.; Donati, M. 1989: Allogeneic bone marrow transplantation for hematological malignancies following therapy with high doses of busulphan and cyclophosphamide Haematologica 74(5): 455-461
Fay, J.W.; Collins, R.H.; Piñeiro, L. 1993: Allogeneic bone marrow transplantation using unrelated marrow donors Bone Marrow Transplantation 11(Suppl 1): 81-82
Gahrton, G.; Bolme, P.; Ljungman, P.; Persson, U.; Ringdén, O. 1993: Bone marrow transplantation. a EEC-project with unrelated donors saves more and more people Lakartidningen 90(10): 948-950
Klein, J.L.; Avalos, B.R.; Belt, P.; Taylor, C.A.; Ezzone, S.A.; Scholl, M.D.; Fisher, J.; Young, D.; Copelan, E.A. 1996: Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy Bone Marrow Transplantation 17(4): 479-483
Shepherd, J.D.; Hoar, D.I.; Keown, P.A.; Phillips, G.L. 1996: Successful paternity of twins following bone marrow transplantation with busulfan, melphalan and cyclophosphamide conditioning Bone Marrow Transplantation 17(3): 461-462
Shaw, P.J.; Stevens, M.M. 1988: Busulphan and cyclophosphamide for pretransplant conditioning Bone Marrow Transplantation 3(4): 367
Hobbs, J.R.; Hugh-Jones, K.; Shaw, P.J.; Downie, C.J.; Williamson, S. 1986: Engraftment rates related to busulphan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children Bone Marrow Transplantation 1(2): 201-208
Harada, M.; Gondo, H.; Taniguchi, S. 1990: Conditioning regimens for diseases treated by allogeneic bone marrow transplantation Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 2013-2022
Kauf, E.; Fuchs, D.; Winnefeld, K.; Hermann, J.; Zintl, F. 1997: Blood selenium content after conditioning and during the course of bone marrow transplantation in children with malignant diseases Medizinische Klinik 92(Suppl 3): 46-47
Nagatoshi, Y.; Okamura, J.; Ikuno, Y.; Akamatsu, M.; Tasaka, H. 1997: Therapeutic trial of intensified conditioning regimen with high-dose cytosine arabinoside, cyclophosphamide and either total body irradiation or busulfan followed by allogeneic bone marrow transplantation for myelodysplastic syndrome in children International Journal of Hematology 65(3): 269-275
Oudshoorn, M.; Falkenburg, J.H.; Ebeling, L.J.; Haak, H.L.; Wijermans, P.W.; Fibbe, W.E.; Willemze, R.; van Rood, J.J. 1996: Unrelated bone marrow transplantation as a rescue procedure following inadvertent loss of an autologous bone marrow graft Bone Marrow Transplantation 18(2): 461-463
Vasta, S.; Scimé, R.; Indovina, A.; Majolino, I. 1992: CNS toxicity and high-dose busulphan in three patients undergoing bone marrow transplantation Haematologica 77(2): 189
Lee, J.H.; Lee, J.H.; Lee, J.S.; Kim, W.K.; Chi, H.S.; Lee, K.H. 2001: Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings Haematologica 86(4): 434-435
Atkinson, K.; Biggs, J.C.; Concannon, A.; Dodds, A.; Honeyman, M.; Doran, T. 1989: One year's experience using the Anthony Nolan Bone Marrow Registry for Australasian patients requiring unrelated marrow transplantation Transplantation Proceedings 21(5): 3815
Dini, G.; Rondelli, R.; Miano, M.; Vossen, J.; Gluckman, E.; Peters, C.; Bordigoni, P.; Locatelli, F.; Miniero, R.; Ljungman, P.; Saarinen, U.; Klingebiel, T.; Ortega, J.; Lanino, E. 1996: Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. the EBMT Paediatric Diseases Working Party Bone Marrow Transplantation 18(Suppl 2): 80-85
Kaminski, E.; Hows, J.; Brookes, P.; Mackinnon, S.; Hughes, T.; Avakian, O.; Sharrock, C.; Goldman, J.; Batchelor, J.R. 1989: Alloreactive cytotoxic T-cell frequency analysis and HLA matching for bone marrow transplants from HLA matched unrelated donors Transplantation Proceedings 21(1 Part 3): 2976-2977
Ueda, M.; Joshi, I.D.; Dan, M.; Uberti, J.P.; Chou, T.H.; Sensenbrenner, L.L.; Lum, L.G. 1993: Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates Transplantation 56(2): 351-356
Weisdorf, D. 1996: Post-transplantation complications of unrelated bone marrow Oncology 10(4): 512; 520
Locasciulli, A.; Alberti, A.; de Bock, R.; Cordonnier, C.; Einsele, H.; Engelhard, D.; Grundy, J.; Reusser, P.; Ribaud, P.; Ljungman, P. 1994: Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party Bone Marrow Transplantation 14(5): 833-837